×
About 1,060 results

ALLMedicine™ Chylothorax Center

Research & Reviews  410 results

Thoracic duct embolization via chest tube for a patient with postoperative traumatic ch...
https://doi.org/10.1503/cjs.022119
Canadian Journal of Surgery. Journal Canadien De Chirurgie; Williams E, Hanna N et. al.

Dec 3rd, 2021 - SummaryWe present the case of a 53-year-old man who experienced a postoperative chyle leak after minimally invasive esophagectomy with mass ligation of the thoracic duct; conservative management failed. Interventional radiology was unsuccessful in...

Chylothorax: A Stepwise Approach to Diagnosis and Treatment.
https://doi.org/10.1891/11-T-705
Neonatal Network : NN; Jackson S, Jnah AJ

Dec 1st, 2021 - Chylothorax, a lymphatic flow disorder characterized by an abnormal circulation of lymph fluid into the pleural cavity, is the most common cause of pleural effusions during the neonatal period. This condition affects 1/15,000 neonates every year. ...

Successfully Reducing Fat-modified Diet Duration for Treating Postoperative Chylothorax...
https://doi.org/10.1016/j.athoracsur.2021.10.028
The Annals of Thoracic Surgery; Winder MM, Vijayarajah S et. al.

Nov 22nd, 2021 - Medical management, primarily a fat-modified diet (FMD), is the mainstay of treatment for the majority of patients with chylothorax. Duration of FMD is traditionally reported as 6 weeks, but no studies demonstrate the shortest effective duration t...

Non-Traumatic Chylothorax and Chylopericardium: Diagnosis and Treatment Using an Algori...
https://doi.org/10.1513/AnnalsATS.202103-262OC
Annals of the American Thoracic Society; Gurevich A, Hur S et. al.

Nov 20th, 2021 - Outcomes of interventional lymphangiographic treatment of nontraumatic chylous pleural effusions using traditional approaches have been highly variable. Recent advances in lymphatic imaging have revealed variations in underlying pathophysiology en...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  4 results

Comparison of LigaSure to Conventional Electrocoagulation in Video-assisted Thoracoscopic Surgery Lobectomy
https://clinicaltrials.gov/ct2/show/NCT03125798

Nov 8th, 2021 - Summary Surgical treatment of lung cancer consists of two elements: anatomical lung resection (segmentectomy, lobectomy or pneumonectomy) followed by mediastinal lymph node sampling (MLNS) or mediastinal lymph node dissection (MLND). Since over la...

Emergency Small vs Large Tube Thoracostomy in Chest Trauma Patients.
https://clinicaltrials.gov/ct2/show/NCT04863989

Apr 28th, 2021 - To evacuate abnormal fluid and air, chest tubes are placed in the pleural space, either surgically or percutaneously. Therapeutic drainage of pleural conditions such as pneumothorax, hemothorax, empyema, chylothorax, and malignant effusions, as we...

Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
https://clinicaltrials.gov/ct2/show/NCT00414648

Aug 28th, 2009 - LAM is an uncommon, progressive, cystic lung disease that predominantly affects young women. It is believed to be caused by defects within cellular pathways that regulate nutrient uptake, cell size, cell migration, and cell proliferation. The dise...

Measurement of Hormonal Concentration in Chylothorax Fluid in Infants With Congenital Chylothorax
https://clinicaltrials.gov/ct2/show/NCT00267345

Mar 1st, 2007 - Late onset Hypothyroidism was found in infant with congenital hypothyroidism. The hypothesis is that infants with congenital hypothyroidism may lose thyroxin and other hormones via the chylothorax fluid causing transient hypothyroidism. In this st...

see more →

News  6 results

Neoadjuvant Chemo Does Not Impact Surgical Risk in Thoracic Esophageal Cancer
https://www.onclive.com/view/neoadjuvant-chemo-does-not-impact-surgical-risk-in-thoracic-esophageal-cancer

Jan 15th, 2021 - Neoadjuvant chemotherapy regimens were not found to increase the risk for perioperative complications in patients who have potentially resectable advanced thoracic esophageal cancer, according to data from the phase 3 JCOG 1109 trial that were vir...

Bilateral chylothorax in an AIDS patient with newly diagnosed Kaposi sarcoma
https://www.mdedge.com/sarcomajournal/article/164190/rare-sarcomas/bilateral-chylothorax-aids-patient-newly-diagnosed

Dec 1st, 2017 - Kaposi sarcoma is an angioproliferative tumor that is associated with human herpes virus-B (HIV-B). Mucocutaneous disease is the most common site for manifestation of AIDS-related Kaposi sarcoma, commonly affecting the lower extremeties, oral muco.

Bilateral chylothorax in an AIDS patient with newly diagnosed Kaposi sarcoma
https://www.mdedge.com/hematology-oncology/article/141507/sarcoma-gist/bilateral-chylothorax-aids-patient-newly-diagnosed
Rebecca Neril et al

Jun 29th, 2017 - Kaposi sarcoma is an angioproliferative tumor that is associated with human herpes virus-8 (HHV-8). Mucocutaneous disease is the most common site for manifestation of AIDS-related Kaposi sarcoma, commonly affecting the lower extremities, oral muco.

Untreated Goiters Larger at Surgery in Men, Minorities, and the Old
https://www.staging.medscape.com/viewarticle/860299

Mar 14th, 2016 - Significant disparities exist in the presentation and outcomes of patients with goiters in the United States, with minority ethnic groups, men, and older patients more likely to present with untreated goiters that have become so large they extend ...

AATS: Avoid mass ligation of the thoracic duct during esophagectomy
https://www.mdedge.com/chestphysician/article/100110/cardiothoracic-surgery/aats-avoid-mass-ligation-thoracic-duct-during
M. Alexander Otto, MDedge News

Jun 1st, 2015 - SEATTLE – Thoracic duct ligation did not seem to prevent chylothorax in a review of 827 esophagectomy cases at Brigham and Women’s Hospital in Boston. In fact, chylothorax was most likely in patients who had mass ligation of the duct and its surro.

see more →